← Back to all trials
Not Yet Recruiting
NCT07836270
A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents
Conditions: Adolescents With Obesity, Adolescents With Overweight & Weight-related Comorbidities
Sex: All
Ages: 12 Years – 17 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 192
Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Location: Children's Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang
Summary
The aim of the study is to evaluate the safety and efficacy of Ecnoglutide injection in overweight or obese Chinese adolescents
Eligibility Criteria
Inclusion Criteria:
1. At screening, the BMI meets the obesity criteria specified in 'WS/T586-2018 Screening for Overweight and Obesity in School-Aged Children and Adolescents', or it meets the overweight criteria and is accompanied by at least one weight-related comorbidity: hyperglycemia, hypertension, dyslipidemia, fatty liver, obstructive sleep apnea syndrome, etc.
2. Participant with body weight loss \
Source: ClinicalTrials.gov (NCT07836270). StuddyBuddy aggregates publicly available trial information.
